Literature DB >> 18539142

mTORC2 regulates PGE2-mediated endothelial cell survival and migration.

Shirine Dada1, Nicolas Demartines, Olivier Dormond.   

Abstract

Prostaglandin E(2) (PGE(2)) promotes angiogenesis by in part inducing endothelial cell survival and migration. The present study examined the role of mTOR and its two complexes, mTORC1 and mTORC2, in PGE(2)-mediated endothelial cell responses. We used small interfering RNA (siRNA) to raptor or rictor to block mTORC1 or mTORC2, respectively. We observed that down-regulation of mTORC2 but not mTORC1 reduced baseline and PGE(2)-induced endothelial cell survival and migration. At the molecular level, we found that knockdown of mTORC2 inhibited PGE(2)-mediated Rac and Akt activation two important signaling intermediaries in endothelial cell migration and survival, respectively. In addition, inhibition of mTORC2 by prolonged exposure of endothelial cells to rapamycin also prevented PGE(2)-mediated endothelial cell survival and migration confirming the results obtained with the siRNA approach. Taken together these results show that mTORC2 but not mTORC1 is an important signaling intermediary in PGE(2)-mediated endothelial cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539142     DOI: 10.1016/j.bbrc.2008.05.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Role of mTOR signaling in tumor cell motility, invasion and metastasis.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Curr Protein Pept Sci       Date:  2011-02       Impact factor: 3.272

2.  Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation.

Authors:  Wenxing Chen; Yan Luo; Lei Liu; Hongyu Zhou; Baoshan Xu; Xiuzhen Han; Tao Shen; Zhijun Liu; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

3.  A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Future Neurol       Date:  2012-11

4.  mTOR-rictor is the Ser473 kinase for AKT1 in mouse one-cell stage embryos.

Authors:  Zhe Zhang; Guojun Zhang; Xiaoyan Xu; Wenhui Su; Bingzhi Yu
Journal:  Mol Cell Biochem       Date:  2011-11-05       Impact factor: 3.396

5.  Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.

Authors:  Ian Damerill; Kyle K Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Endocrinol       Date:  2015-12-29

6.  COX2 is induced in the ovarian epithelium during ovulatory wound repair and promotes cell survival†.

Authors:  Lauren E Carter; David P Cook; Olga Collins; Lisa F Gamwell; Holly A Dempster; Howard W Wong; Curtis W McCloskey; Ken Garson; Nhung H Vuong; Barbara C Vanderhyden
Journal:  Biol Reprod       Date:  2019-11-21       Impact factor: 4.285

7.  The syndecan-4/protein kinase Cα pathway mediates prostaglandin E2-induced extracellular regulated kinase (ERK) activation in endothelial cells and angiogenesis in vivo.

Authors:  Federico Corti; Federica Finetti; Marina Ziche; Michael Simons
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

8.  Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway.

Authors:  Lei Liu; Long Chen; Yan Luo; Wenxing Chen; Hongyu Zhou; Baoshan Xu; Xiuzhen Han; Tao Shen; Shile Huang
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

9.  Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1.

Authors:  Stephanie C Moss; Daniel J Lightell; Steven O Marx; Andrew R Marks; T Cooper Woods
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

Review 10.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.